ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,490, issued on May 20, was assigned to CK Regeon Inc. (Seoul, South Korea).
"Compositions and methods for suppressing and/or treating neurodegenerative diseases and/or a clinical condition thereof" was invented by Kang-Yell Choi (Seoul, South Korea), Minguen Yoon (Seoul, South Korea) and Soung-Hoon Lee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "Therapeutic compositions comprising one or more agents that inhibit CXXC5-DVL interface and/or that enhance the activity of GLP-1, and methods of administering those therapeutic compositions to model, treat, reduce resistance to treatment, prevent and diagnose a condition/disease assoc...